Gilead (GILD) announced that Keeley Wettan will be appointed executive VP, general counsel, legal and compliance effective immediately. She will join the company’s senior leadership team and report to chairman and CEO Daniel O’Day. Wettan has held increasingly senior legal leadership roles within Gilead during her 14-year tenure, most recently as senior VP leading the global legal business partners team.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead Sciences: Strategic Expansion in HIV Treatment Bolsters Buy Rating
- Gilead announces ARTISTRY-2 trial met primary success criterion
- The Week That Was, The Week Ahead: Macro & Markets, Dec. 14
- Arcus Biosciences Stock (RCUS) Collapses 17% after Failed Stomach Cancer Study
- Arcus Biosciences announces discontinuation of STAR-221 study